Author:
Tsurushima Hideo,Liu Shu Qin,Tsuboi Koji,Yoshii Yoshihiko,Nose Tadao,Ohno Tadao
Abstract
✓ The authors induced autologous cytotoxic T lymphocytes (CTLs) directly from peripheral blood lymphocytes by preparing a coculture of minced tissue fragments of glioblastoma multiforme (GBM) with interleukins-1, -2, -4, and -6 and interferon-g in RHAMa medium containing 5% autologous plasma for 2 weeks. At the end of this period, the frequencies of CD3+, CD4+, CD8+, and CD16+ lymphocytes were 95% to 99%, 40% to 62%, 37% to 38%, and 0.2%, respectively. The lymphocytes killed 82% to 100% of the GBM cells within 48 hours at an effector-to-target cell ratio of 1.67, whereas in a separate coculture, autologous lymphokine-activated killer (LAK) cells killed only 33% of GBM cells under the same conditions. The lymphocytes showed no cytotoxicity against LAK-sensitive Daudi cells, natural killer—sensitive K562 cells or autologous fibroblasts grown from the brain tumor, although they did show slight cytotoxicities against allogeneic GBM cell lines. These results lead the authors to suggest that the lymphocyte population contains specific CTLs for autologous brain tumor cells and that these CTLs could be effective in adoptive immunotherapy to combat brain tumor.
Publisher
Journal of Neurosurgery Publishing Group (JNSPG)
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Adoptive cell therapy for glioma;Immunotherapeutic Strategies for the Treatment of Glioma;2022
2. Immune Response: Glioma-Associated Immunosuppression;Glioma Cell Biology;2014
3. Immunotherapy for Glioma;Neurosurgery Clinics of North America;2012-07
4. Adoptive Cell Transfer Therapy For Malignant Gliomas;Advances in Experimental Medicine and Biology;2012
5. Biologic Principles of Immunotherapy for Malignant Gliomas;Neurosurgery Clinics of North America;2010-01